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P atients with non-ST segment elevation acute coronary syndromes (ACS) represent a heterogeneous group with varying risk of death and ischemic complications. These patients should be risk stratified to determine the need for early revascularization versus a conservative approach with medical therapy alone. 1 The Thrombolysis in Myocardial Infarction (TIMI) Risk score is a validated prognostication tool, which has shown to predict the risk of death and ischemic complications in patients with acute coronary syndrome. 2 Despite the availability of risk stratification tools, there is wide variability in clinical practice regarding the decision to invasively manage patients with non-ST elevation ACS. 3 Several studies have examined the impact of geographic location and availability of on-site angiography on referral patterns. These studies have consistently shown that patients admitted with ACS are more likely to undergo coronary angiography, and experience shorter wait times, if they are admitted to a hospital with on-site cardiac catheterization facilities. [3] [4] [5] Studies have also shown that risk stratification tools are underutilized in the selection of an invasive versus conservative strategy. 6 To our knowledge, there are no recent studies that have compared the referral patterns for cardiac catheterization at hospitals with and without catheterization facilities, according to initial risk assessment (e.g., Thrombolysis in Myocardial Infarction [TIMI] Risk score). The primary objective of this study was to examine the pattern of angiogram referrals in patients with non-ST elevation ACS based on the TIMI risk score at sites with and without catheterization facilities.
Despite recent advances in revascularization procedures, medical therapy remains as the cornerstone of treatment for coronary artery disease (CAD). Optimal use of medical therapy and risk factor modification strategies are still likely to be the most effective interventions with respect to mortality reduction in patients with CAD. 6 A secondary objective of this study was H a r o u n e t a l . V o l u m e 9 , I s s u e 3 , 2 0 1 4
to investigate adherence to current guidelines for secondary prevention including use of evidence-based medical therapies, referrals to cardiac rehabilitation and smoking cessation programs.
1
Methods

Study Setting
The study was conducted at two academic teaching hospitals in Hamilton, Ontario: Hamilton General Hospital (Site A) which has on-site catheterization facilities and St. Joseph's Healthcare (Site B) which does not. This study was approved by the Hamilton Health Sciences and St. Joseph's Healthcare Research Ethics Boards.
Patient Population
We performed a retrospective study of consecutive patients admitted to the two hospitals with a diagnosis of unstable angina (UA) or non-ST elevation myocardial infarction (NSTEMI) between January 2009 and October 2010. To investigate the impact of on-site cardiac catheterization availability on clinical decisions, patients were divided according to the presence (Site A) or absence (Site B) of such facilities at the admitting hospital. We included patients over the age of 18 years who had an emergency department (ED) diagnosis of ACS, NSTEMI, or UA. Exclusion criteria included: an ED diagnosis of ST elevation myocardial infarction (STEMI); ischemia refractory to nitroglycerin infusion; congestive heart failure (CHF) refractory to medical therapy; cardiogenic shock; patient refusal of cardiac catheterization; physician decision not to refer for cardiac catheterization based on patient comorbidities. 
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Data Collection
Data was abstracted from medical records by four trained investigators. Admission data included patient demographics, cardiac risk factors, the presence of ECG changes (≥ 0.5 mm ST segment deviation) and cardiac biomarkers (troponin T), serum creatinine, and admission medications. We used the chartabstracted data to calculate the TIMI risk score for each patient. We recorded referrals for non-invasive testing, cardiac catheterization and revascularization procedures. Wait times for cardiac catheterization and duration of hospital stay were recorded. The use of secondary prevention strategies was evaluated by recording discharge medications and referrals to cardiac rehabilitation as well as smoking cessation programs.
To ensure concordance between data extractors, all four investigators extracted data from a training set of 30 charts. Cohen's kappa coefficient for the TIMI risk score was 0.77.
Statistical Analysis
We compared patient data at the two sites using the Student's t test for continuous variables and the Fishers' exact test for categorical variables. Referral rates for cardiac catheterization were compared across low (0-2), intermediate (3) (4) and high (5-7) TIMI risk groups between the two sites using the Student's t test.
We analyzed univariable associations of hospital site and cardiac catheterization referrals, TIMI risk score, serum creatinine, prior history of CAD, prior cardiac catheterization, and prior revascularization procedures. We used logistic regression to perform a multivariate analysis in order to evaluate the independent association between hospital site and angiogram referrals.
Results
Patient Population
A total of 397 patients were included in the study. Overall, patients at the two sites had a similar risk profile (median TIMI score of 3 at each site). The groups at each site were similar with respect to age, gender, and most risk factors for CAD (Table 1) . However, patients admitted to Site A had higher rates of known CAD and prior revascularization procedures, while patients H a r o u n e t a l . 
Predictors of Cardiac Catheterization Referrals
Overall, availability of on-site cardiac catheterization did not have a significant impact on catheterization referral rates ( Table 2) . The strongest predictors of cardiac catheterization referrals were the presence of ECG changes (adjusted OR 5.44, 95% CI 2.29-12.95, p < .0001) and positive cardiac biomarkers (adjusted OR 3.91, 95% CI 2.10-7.27 p < .0001).
Cardiac Catheterization Referrals Stratified by TIMI Risk Score
An invasive approach was selected in the majority of high-risk patients (TIMI>4), (Site A 72.0% vs. Site B 65.7%, p = .21), with very few high-risk patients referred for noninvasive testing (Site A 8.0% vs. Site B 11.4%, p = 0.42) ( Table 3 ). Low risk patients (TIMI <3) were managed conservatively in most cases, but were more often referred for angiography at the site without PCI available (Site A 26.9% vs. Site B 37.2%, p = .03). Intermediate risk patients (TIMI 3-4) were much more likely to be referred for angiography if admitted to the hospital with on-site catheterization facilities (Site A 53.9% vs. Site B 32.6%, p = .001).
Wait Times
Among patients referred for cardiac catheterization, there was no difference in the time delay from referral date to the procedure date between the two sites (1.9 days at Site A vs. 2.2 days at Site B, p = .38) (Figure 1 ). Overall, there was a trend towards a shorter length of stay for patients admitted to the hospital with on-site cardiac catheterization facilities, but this was not statistically significant (3.6 days at Site A vs. 4.2 days at Site B, p = .20).
Use of Secondary Prevention Strategies
In our study, 89.5% and 91.3% of patients were discharged home on aspirin therapy from Site A and Site B, respectively. However, only 64.5% and 65.3% of patients were discharged on clopidogrel. The frequencies of medication use at the time of discharge are shown in Table 4 . Approximately 23% of included patients were identified as current smokers. However, only 12.8% (Site A) and 2.3% (Site B) of current smokers were referred to smoking cessation programs. Referral rates to cardiac rehabilitation programs were 11.5% and 14.5% at Site A and Site B respectively.
Discussion
In both the univariate analysis and adjusted analyses, we found no association between hospital site and the decision to refer patients for angiography. When stratified by TIMI risk group, most low risk patients were appropriately managed conservatively, while the majority of high-risk patients underwent angiography. Wait times for cardiac catheterization and total length of hospital stay did not differ significantly between sites. Our findings contrast with those of previous studies, which have identified hospital site as an important predictor of angiography referrals and total length of stay. 3 This may reflect the impact of regional referral strategies and recent efforts to reduce wait times by the Cardiac Care Network (CCN) of Ontario. This working group was established in an effort to improve patient access to centralized cardiac care across the province in the last twenty years.
Overall, use of medical therapies was high in our study population. The use of aspirin, beta-blockers and ACE inhibitors or ARBs demonstrated an improvement in adherence to guidelines compared to previous studies which demonstrated aspirin use in less than 80% of patients, and the use of statins and ACE inhibitors in less than 50% of patients at hospital discharge. [7] [8] [9] Two-thirds of patients were prescribed dual antiplatelet therapy at the time of hospital discharge. Clopidogrel has been shown to reduce ischemic complications in patients with non ST-segment elevation ACS who have dynamic ECG changes, positive cardiac biomarkers or who undergo revascularization. 10 Less than 50% of patients in our study met these clinical criteria and therefore more selective use of clopidogrel was likely appropriate.
With regards to non-pharmacological, secondary prevention strategies, referral rates to cardiac rehabilitation and smoking cessation programs were extremely low at both hospitals. Cardiac rehabilitation in patients post myocardial infarction has been shown to reduce recurrent ischemic events and cardiovascular mortality. 11, 12 The low referral rates observed in our study suggest there is a need for education regarding the efficacy and availability of supervised exercise programs in patients with CAD. This might represent an opportunity to improve the quality of care in ACS patients.
Limitations
Our study has limitations as a result of its retrospective design and relatively small sample size. However, it is unlikely that a larger sample size would have significantly altered the main observations of this study. We observed a trend towards higher rates of angiogram referrals at the centre with on-site angiography, but this did not reach statistical significance. Perhaps a larger study would have demonstrated this difference to be significant, with more patients being referred at hospitals with on-site facilities. With this in mind, our study did demonstrate significant underuse of certain secondary prevention strategies despite the limitations in sample size. Arguably, this message is of greater significance, as medical therapy is still the cornerstone of coronary artery disease management.
Conclusion
Our study showed that referrals for cardiac catheterization for patients with non-ST segment elevation ACS seem to be both timely and appropriate, regardless of availability of on-site cardiac catheterization. Use of evidence based medical therapies in ACS has improved in comparison to previous reports. However, cardiac rehabilitation and smoking cessation programs were significantly underutilized. Although there have been significant improvements in access to invasive procedures, there remain important gaps in secondary prevention strategies which represent important opportunities to improve quality of care in these patients.
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